Frontlight ResearchEarly access
Trial site
Azienda Ospedaliera Ospedali Riuniti Marche Nord
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Myeloproliferative neoplasms3 trials
- Acute lymphoblastic leukaemia2 trials
- Acute myeloid leukaemia2 trials
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Mesothelioma1 trial
- Phase
- Phase 36 trials
- Phase 25 trials
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto2 trials
- Bristol-Myers Squibb1 trial
- Fondazione Gimema Franco Mandelli Onlus1 trial
- Fondazione GONO G.I.1 trial
- Gilead Sciences1 trial
- and 5 more
Running trials
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026